Terapia innovativa: oltre il PEB? Relatore: Dr ... - Oncologia Rimini
Terapia innovativa: oltre il PEB? Relatore: Dr ... - Oncologia Rimini
Terapia innovativa: oltre il PEB? Relatore: Dr ... - Oncologia Rimini
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Prognostic factors in relapsed or refractory germ-cell tumors<br />
ASCO 2009 - Abstr # 5030<br />
A. Lorch, J. Beyer , C. Mollevi, M. Guerra, A. Kramar for the International Group on<br />
Prognostic Factors in Relapsed or Refractory Germ-Cell Tumors<br />
VALUTAZIONI IN CORSO:<br />
Chemotherapy<br />
Conventional vs<br />
HDCT<br />
Number of HD cycles (N=821)<br />
Single vs<br />
Sequential<br />
Only Conventional regimens<br />
(N=773)<br />
TIP vs<br />
Other combination